文献
J-GLOBAL ID:202002254183419489
整理番号:20A0122744
良好な予後(Flyer)を伴う攻撃性B細胞リンパ腫患者におけるリツキシマブの6つの応用と併用したCHOP化学療法の4対6サイクル:無作為化第3相非劣性試験【JST・京大機械翻訳】
Four versus six cycles of CHOP chemotherapy in combination with six applications of rituximab in patients with aggressive B-cell lymphoma with favourable prognosis (FLYER): a randomised, phase 3, non-inferiority trial
著者 (44件):
Poeschel Viola
(Department of Internal Medicine 1 (Oncology, Hematology, Clinical Immunology, and Rheumatology), Saarland University Medical School, Homburg/Saar, Germany)
,
Held Gerhard
(Department of Internal Medicine 1, Westpfalz-Klinikum, Kaiserslautern, Germany)
,
Ziepert Marita
(Institute for Medical Informatics, Statistics and Epidemiology, University Leipzig, Leipzig, Germany)
,
Witzens-Harig Mathias
(Department of Internal Medicine V, University of Heidelberg, Heidelberg, Germany)
,
Holte Harald
(Department of Oncology, Oslo University Hospital, Oslo, Norway)
,
Thurner Lorenz
(Department of Internal Medicine 1 (Oncology, Hematology, Clinical Immunology, and Rheumatology), Saarland University Medical School, Homburg/Saar, Germany)
,
Borchmann Peter
(Department of Hematology and Oncology, University Hospital of Cologne, Cologne, Germany)
,
Viardot Andreas
(Department of Internal Medicine III, University Hospital Ulm, Ulm, Germany)
,
Soekler Martin
(Department of Internal Medicine II, University Hospital Tuebingen, Tuebingen, Germany)
,
Keller Ulrich
(Department of Internal Medicine III, Klinikum Rechts der Isar der TU Muenchen, Munich, Germany)
,
Schmidt Christian
(Department of Medicine III, University Hospital, Munich, Germany)
,
Truemper Lorenz
(Department of Hematology and Oncology, Georg August University of Goettingen, Goettingen, Germany)
,
Mahlberg Rolf
(Department of Internal Medicine I, Klinikum Mutterhaus der Borromaerinnen, Trier, Germany)
,
Marks Reinhard
(Department of Hematology and Oncology, University Medical Center, Freiburg, Germany)
,
Hoeffkes Heinz-Gert
(Klinikum Fulda Tumorklinik, Fulda, Germany)
,
Metzner Bernd
(Department of Hematology and Oncology, Klinikum Oldenburg, Oldenburg, Germany)
,
Dierlamm Judith
(Department of Internal Medicine II, University Hospital Eppendorf, Hamburg, Germany)
,
Frickhofen Norbert
(Department of Internal Medicine III, Dr Horst-Schmidt-Kliniken Wiesbaden, Wiesbaden, Germany)
,
Haenel Mathias
(Department of Internal Medicine III, Kuechwald Hospital Chemnitz, Chemnitz, Germany)
,
Neubauer Andreas
(Department of Hematology, Oncology and Immunology, University Hospital Marburg, Marburg, Germany)
,
Kneba Michael
(Department of Internal Medicine II, City Hospital Kiel, Kiel, Germany)
,
Merli Francesco
(Hematology Azienda Unita Sanitarie Locali-Istituto di Ricovero e Cura a Carattere Scientifico di Reggio Emilia, Reggio Emilia, Italy)
,
Tucci Alessandra
(Hematology Azienda Socio Sanitaria Territoriale Spedali Civili Brescia, Brescia, Italy)
,
de Nully Brown Peter
(Department of Hematology, Rigshospitalet, Copenhagen, Denmark)
,
Federico Massimo
(Dipartimento Chirurgico, Medico, Odontoiatrico e di Scienze Morfologiche con Interesse Trapiantologico, Oncologico e di Medicina Rigenerativa, University of Modena and Reggio Emilia, Modena, Italy)
,
Lengfelder Eva
(Department of Internal Medicine III, University Hospital Mannheim, Mannheim, Germany)
,
di Rocco Alice
(Department of Translational and Precision Medicine, Sapienza University of Rome, Rome, Italy)
,
Trappe Ralf
(Department of Internal Medicine II, Evangelisches Diakonie-Krankenhaus, Bremen, Germany)
,
Rosenwald Andreas
(Institute of Pathology, University of Wuerzburg, and Comprehensive Cancer Center Mainfranken, Wuerzburg, Germany)
,
Berdel Christian
(Department of Radiooncology, Saarland University Medical School, Homburg/Saar, Germany)
,
Maisenhoelder Martin
(Department of Oncology, University Hospital of North Norway, Tromso, Norway)
,
Shpilberg Ofer
(Department of Hematology, Rabin Medical Center, Beilinson Hospital, Petah-Tiqwa, Israel)
,
Amam Josif
(Department of Internal Medicine 1 (Oncology, Hematology, Clinical Immunology, and Rheumatology), Saarland University Medical School, Homburg/Saar, Germany)
,
Christofyllakis Konstantinos
(Department of Internal Medicine 1 (Oncology, Hematology, Clinical Immunology, and Rheumatology), Saarland University Medical School, Homburg/Saar, Germany)
,
Hartmann Frank
(Department of Internal Medicine 1 (Oncology, Hematology, Clinical Immunology, and Rheumatology), Saarland University Medical School, Homburg/Saar, Germany)
,
Murawski Niels
(Department of Internal Medicine 1 (Oncology, Hematology, Clinical Immunology, and Rheumatology), Saarland University Medical School, Homburg/Saar, Germany)
,
Stilgenbauer Stephan
(Department of Internal Medicine 1 (Oncology, Hematology, Clinical Immunology, and Rheumatology), Saarland University Medical School, Homburg/Saar, Germany)
,
Nickelsen Maike
(Department of Hematology, Oncology and Stem Cell Transplantation, Asklepios Klinik St Georg, Hamburg, Germany)
,
Wulf Gerald
(Department of Hematology and Oncology, Georg August University of Goettingen, Goettingen, Germany)
,
Glass Bertram
(Department of Hematology, Oncology and Stem Cell Transplantation, Asklepios Klinik St Georg, Hamburg, Germany)
,
Schmitz Norbert
(Department of Hematology, Oncology and Stem Cell Transplantation, Asklepios Klinik St Georg, Hamburg, Germany)
,
Altmann Bettina
(Institute for Medical Informatics, Statistics and Epidemiology, University Leipzig, Leipzig, Germany)
,
Loeffler Markus
(Institute for Medical Informatics, Statistics and Epidemiology, University Leipzig, Leipzig, Germany)
,
Pfreundschuh Michael
(Department of Internal Medicine 1 (Oncology, Hematology, Clinical Immunology, and Rheumatology), Saarland University Medical School, Homburg/Saar, Germany)
資料名:
Lancet
(Lancet)
巻:
394
号:
10216
ページ:
2271-2281
発行年:
2019年
JST資料番号:
B0673A
ISSN:
0140-6736
CODEN:
LANCA
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
オランダ (NLD)
言語:
英語 (EN)